1.
Inflamm Bowel Dis
; 2023 Apr 18.
Article
in English
| MEDLINE | ID: covidwho-2303231
2.
Dig Dis Sci
; 68(5): 2158-2160, 2023 05.
Article
in English
| MEDLINE | ID: covidwho-2280093
3.
Inflamm Bowel Dis
; 2023 Feb 15.
Article
in English
| MEDLINE | ID: covidwho-2239482
ABSTRACT
We evaluated antibody concentrations 6 months after a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. Almost all patients had an antibody response, and those with a previous SARS-CoV-2 infection had higher antibody concentrations.
4.
The American Journal of Gastroenterology
; 117(10S), 2022.
Article
in English
| ProQuest Central | ID: covidwho-2111060
5.
Gastroenterology
; 162(7):S-596-S-597, 2022.
Article
in English
| EuropePMC | ID: covidwho-1905283
6.
Inflamm Bowel Dis
; 28(11): 1781-1786, 2022 11 02.
Article
in English
| MEDLINE | ID: covidwho-1784354
ABSTRACT
Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.